Technical Articles
11 Apr 2025
Crystal’s Perspective: Polymorph Patent Landscape of 28 FDA-Approved Small Molecule Drugs in 2024
11 Apr 2025
Crystal Pharmatech is Heading to DCAT Week 2025! Meet Our Leadership Team.
We’re excited to be in New York City from March 17-20 for DCAT Week 2025! Our leadership team will be there to connect and discuss the latest in small molecule drug development and CMC strategies.
Date: March 17-20
Location: Hotel 48 Lex, Suite 904
517 Lexington Ave, New York City, New York, USA
Attendee:
Alex Chen, Ph.D. – Co-founder & CEO
Robert Wenslow, Ph.D. – Co-founder & CBO
Yongqiang Li, Ph.D. – CEO of Canada CDMO BU (Candoo)
Derik McCarthy – Subject Matter Expert
Yan Li – Senior Director
Book Meeting https://outlook.office365.com/book/DCAT20251@crystalpharmatech.com/